Showing 271-280 of 351 grants

Title Institution Researcher Program Duration Total Award Amount
Targeting pathogenic Th17 cells as shared mechanisms in MS, SLE and T1D Icahn School of Medicine at Mount Sinai Ka Lung Cheung Cures 01-September-2026 to 31-August-2027 $149,950.03
Enhancing Functional Maturation of Stem Cell-Derived Beta Cells Using Harmine for Improved Diabetes Therapy Icahn School of Medicine at Mount Sinai Peng Wang Cures 01-July-2025 to 31-December-2026 $305,000.00
Protective Genetic and Pharmacological Interventions to Prevent Cytokine and Autoimmune-based Destruction of β cells. Icahn School of Medicine at Mount Sinai Romina Bevacqua Cures 01-April-2025 to 31-March-2027 $559,996.54
Protective Interventions against Loss of Function and Destruction of β cells in Type 1 Diabetes. Icahn School of Medicine at Mount Sinai Romina Bevacqua Cures 01-March-2026 to 28-February-2031 $999,999.00
Cardiotoxic Circulating Extracellular Vesicles: New Drivers of Type 1 Diabetes-induced Cardiomyopathy Icahn School of Medicine at Mount Sinai Susmita Sahoo Improving Lives 01-April-2025 to 30-September-2026 $199,998.24
Defining antigen-presenting cell – CD8 T cell crosstalk in type 1 diabetes using uLIPSTIC Icahn School of Medicine at Mount Sinai Verena van der Heide Cures 01-May-2026 to 30-April-2029 $600,000.00
Development and Preclinical Assessment of a Biovascular Pancreas Humacyte Kaleb Naegeli Cures 01-April-2023 to 28-February-2027 $863,333.00
Goals of Care Among Caregivers of Youth with T1D Using The 3-Act Model Hugo W. Moser Research Institute at Kennedy Krieger Karen Dimentstein Transportfolio 01-September-2024 to 31-August-2026 $128,399.18
T1D Cures Accelerator Health and Environmental Sciences Institute: Home – HESI Syril Pettit Cures 01-October-2026 to 30-September-2029 $1,499,197.46
Creation of a Commercializable Multi-Omics Resource from T1D Patient-Derived iPSC-Derived 3D Islet Organoid Models Greenstone Biosciences, Inc. Angelos Oikonomopoulos Cures 25-June-2026 to 24-June-2029 $1,200,000.00